Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluat...
Q2 2026
Aug 6, 2026
Q1 2026
May 8, 2026
FY 2025
Feb 27, 2026
Q4 2025
Q3 2025
Nov 7, 2025